Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Meningitis Preventive Vaccines - Pipeline Analysis and Market Forecasts to' returned 14 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom 2012 France Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 980 with Positive Patients from Non-endemic Areas - Patient - Laboratory - Physician c. Vaccines and Drugs 41. Measles (Rubeola) a. Background b. Diagnostic Tests c. Vaccines and Drugs 42. Meningitis a. Background b 2012 Japan Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 976 of the Newborn -Acute Aseptic Meningitis -Undifferentiated Febrile Illness -Fever with upper respiratory infection -Encephalitis -Asymptomatic Infection b. Diagnostic Tests c. Vaccines and Drugs 18. Creutzfeldt 2012 Italy Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 970 of Detecting HDV - Prevention f. Hepatitis E - Background - Prevalence of the Disease - Diagnostic Tests - Epidemiologic Serosurveys - Serologic Cross-Reactivity g. Hepatitis G - Vaccines and Drugs 34. Herpes Global Microbiology Testing Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers   Venture Planning Group, June 2011, Pages: 1900 Market Segmentation Analysis - Sales and market shares of major suppliers of microbiology products, by country and individual test. Test and sales forecasts for over 90 microbiology assays by country, individual test 2012 Germany Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 983 - Laboratory - Physician c. Vaccines and Drugs 41. Measles (Rubeola) a. Background b. Diagnostic Tests c. Vaccines and Drugs 42. Meningitis a. Background b. Diagnostic Tests c. Vaccines and Drugs -- Development 2012 Spain Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 960 - Laboratory - Physician c. Vaccines and Drugs 41. Measles (Rubeola) a. Background b. Diagnostic Tests c. Vaccines and Drugs 42. Meningitis a. Background b. Diagnostic Tests c. Vaccines and Drugs -- Development European Vaccines Market   Frost & Sullivan, Jan 2006 of the European vaccines market, including revenue forecasts until 2012. Global Trends This research service includes analysis of the global vaccines market, thus providing an overview of the market trends 2012 Global Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 1900 - Patient - Laboratory - Physician c. Vaccines and Drugs 41. Measles (Rubeola) a. Background b. Diagnostic Tests c. Vaccines and Drugs 42. Meningitis a. Background b. Diagnostic Tests c. Vaccines and Drugs Future US Microbiology Testing Market Outlook   Venture Planning Group, Feb 2012, Pages: 1037 Prevention f. Hepatitis E 0 Background 0 Prevalence of the Disease 0 Diagnostic Tests 0 Epidemiologic Serosurveys 0 Serologic Cross-Reactivity g. Hepatitis G 0 Vaccines and Drugs 34. Herpes Simplex The 2011 German Infectious Disease Testing Market   Venture Planning Group, April 2010, Pages: 983 " - Methods of Detecting HDV - Prevention f. Hepatitis E - Background - Prevalence of the Disease - Diagnostic Tests - Epidemiologic Serosurveys - Serologic Cross-Reactivity g. Hepatitis G - Vaccines and Drugs 2012 UK Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 978 - Laboratory - Physician c. Vaccines and Drugs 41. Measles (Rubeola) a. Background b. Diagnostic Tests c. Vaccines and Drugs 42. Meningitis a. Background b. Diagnostic Tests c. Vaccines and Drugs -- Development Neuroprotection - Drugs, Markets and Companies   Jain PharmaBiotech, May 2012, Pages: 633 receptor blockade Stroke vaccine SUN N4057 Thrombosis inhibitors Aspirin Clopidogrel Dipyridamole Vitamin E for neuroprotection in stroke Neuroprotection in reperfusion injury Prevention Molecular Diagnostics - Technologies, Markets and Companies   Jain PharmaBiotech, May 2012, Pages: 1037 to technologies, applications and geographical regions. Forecasts are made up to 2021. A major portion of the molecular diagnostic market can be attributed to advances in genomics and proteomics. Biochip Molecular Diagnostics - Global Strategic Business Report   Global Industry Analysts, Inc., Oct 2010, Pages: 659 , Pharmacogenomics, and Cancer Screening. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets2    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network